Search results

Blog

Case Study: How Altasciences Launched a Phase I Study 70% Faster Than the Industry Standard

Dec 9, 2024

Discover how Altasciences reduced clinical trial start-up timelines by 70%, initiating the first dose of a Phase I MAD study in just 3.5 weeks.
- Clinical Trials
Press Release

Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services

Nov 13, 2024
- Bioanalysis
Scientific Publication

Altasciences' Truly Integrated Platform

Jan 2, 2024
News

Insights Care: Canada's Most Visionary Male Leaders in Healthcare to Follow 2023 — Chris Perkin, CEO at Altasciences

Nov 30, 2023
Scientific Publication

Proactive Drug Development for Large Molecules

Nov 23, 2023
- Preclinical Research
Blog

Exploring the Advantages of Canada for Early-Phase Clinical Trials

Oct 31, 2023

Explore Canada `s advantages for early-phase clinical trials: streamlined regulatory pathways, diverse participant pool, and cost-effectiveness.
- Regulatory Affairs
Scientific Publication

Screening for Pre-Existing Antibodies to Adenovirus for Nonclinical Gene Therapy Programs

Dec 12, 2024